Vascular-targeted TNFα and IFNγ inhibits orthotopic colorectal tumor growth

Vascular-targeted TNFα improves tumor blood vessel function and enhances antitumor immunity and chemotherapy in colorectal cancer

(2015) Lan Lu et al.   JOURNAL OF CONTROLLED RELEASE

Targeted drug delivery for cancer therapy: the other side of antibodies

(2012) Michael A Firer et al.   Journal of Hematology & Oncology

Selective Targeting of Interferon   to Stromal Fibroblasts and Pericytes as a Novel Therapeutic Approach to Inhibit Angiogenesis and Tumor Growth

(2012) R. Bansal et al.   MOLECULAR CANCER THERAPEUTICS

Tumor-targeted TNF  stabilizes tumor vessels and enhances active immunotherapy

(2012) A. Johansson et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Chromogranin A Restricts Drug Penetration and Limits the Ability of NGR-TNF to Enhance Chemotherapeutic Efficacy

(2011) E. Dondossola et al.   CANCER RESEARCH

Phase I Study of NGR-hTNF, a Selective Vascular Targeting Agent, in Combination with Cisplatin in Refractory Solid Tumors

(2011) V. Gregorc et al.   CLINICAL CANCER RESEARCH

Vandetanib Improves Anti-Tumor Effects of L19mTNF  in Xenograft Models of Esophageal Cancer

(2010) M. Crescenzi et al.   CLINICAL CANCER RESEARCH

Phase II study of NGR-hTNF, a selective vascular targeting agent, in patients with metastatic colorectal cancer after failure of standard therapy

(2010) Armando Santoro et al.   EUROPEAN JOURNAL OF CANCER

Phase II Study of Asparagine-Glycine-Arginine–Human Tumor Necrosis Factor α, a Selective Vascular Targeting Agent, in Previously Treated Patients With Malignant Pleural Mesothelioma

(2010) Vanesa Gregorc et al.   JOURNAL OF CLINICAL ONCOLOGY

A novel peptide specifically targeting the vasculature of orthotopic colorectal cancer for imaging detection and drug delivery

(2010) Zhi Jie Li et al.   JOURNAL OF CONTROLLED RELEASE

Phase Ib study of NGR–hTNF, a selective vascular targeting agent, administered at low doses in combination with doxorubicin to patients with advanced solid tumours

(2009) V Gregorc et al.   BRITISH JOURNAL OF CANCER

Targeted therapy of renal cell carcinoma: Synergistic activity of cG250-TNF and IFNg

(2009) Stefan Bauer et al.   INTERNATIONAL JOURNAL OF CANCER

Molecular Mechanisms of IFN-γ to Up-Regulate MHC Class I Antigen Processing and Presentation

(2009) Fang Zhou   INTERNATIONAL REVIEWS OF IMMUNOLOGY

Tumor vasculature-targeted delivery of tumor necrosis factor-α*

(2008) Anita Tandle et al.   CANCER

Specific targeting of the vasculature of gastric cancer by a new tumor-homing peptide CGNSNPKSC

(2008) Xiaoli Hui et al.   JOURNAL OF CONTROLLED RELEASE

Targeted Delivery of Murine IFN-γ Using a Recombinant Fowlpox Virus: NK Cell Recruitment to Regional Lymph Nodes and Priming of Tumor-Specific Host Immunity

(2008) Hasan Zeytin et al.   JOURNAL OF INTERFERON AND CYTOKINE RESEARCH

Vasculature-targeted tumor necrosis factor-alpha increases the therapeutic index of doxorubicin against prostate cancer

(2008) Maria T.S. Bertilaccio et al.   PROSTATE